Reactions Weekly

, Volume 1770, Issue 1, pp 313–313 | Cite as


Various toxicities: 16 case reports
Case report


  1. Swami U, et al. Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events. Journal of Oncology 2019: 25 Jul 2019. Available from: URL: - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations